EXPERT REACTION: South Australian COVID-19 vaccine trial clears phase 1
Not peer-reviewed: This work has not been scrutinised by independent experts, or the story does not contain research data to review (for example an opinion piece). If you are reporting on research that has yet to go through peer-review (eg. conference abstracts and preprints) be aware that the findings can change during the peer review process.
It is being reported today that South Australian company Vaxine is to begin phase two trials of its COVID-19 vaccine after the vaccine was found to be safe and generate an immune response in phase one trials. Led by Professor Nikolai Petrovsky from Flinders University, phase one trials began at the beginning of the month, with the company yet to release any data or peer-reviewed research on the trials. Below, an Australian expert responds.
Organisation/s: Australian Science Media Centre, Mater Research, The University of Queensland
Funder: N/A
Attachments:
Note: Not all attachments are visible to the general public
News for:
Australia
QLD
SA
Media contact details for this story are only visible to registered journalists.
Expert Reaction
These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.